Grant Masaaki Shibuya

Title: Grant Masaaki Shibuya: Innovator in G Protein-Coupled Receptor Modulators

Introduction

Grant Masaaki Shibuya is a prominent inventor based in South San Francisco, CA. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target G protein-coupled receptors. With a total of eight patents to his name, Shibuya's work has the potential to impact therapeutic approaches in various medical conditions.

Latest Patents

Among his latest patents, Shibuya has developed methods for synthesizing trans isomeric forms of G protein-coupled receptor modulators. This patent discloses methods for creating a trans isomeric compound of a C—C chemokine receptor type 4 (CCR4) modulator, which is crucial for enhancing the efficacy of therapeutic agents. Another notable patent involves pyrazole pyrimidine compounds that modulate and inhibit hematopoietic progenitor kinase 1. This innovation includes methods for synthesizing these compounds and outlines therapeutic applications for their use.

Career Highlights

Throughout his career, Grant Masaaki Shibuya has worked with notable organizations such as SiteOne Therapeutics, Inc. and Leland Stanford Junior University. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Shibuya has collaborated with esteemed colleagues, including John Mulcahy and Hassan Pajouhesh. These partnerships have fostered an environment of innovation and have led to the advancement of new therapeutic strategies.

Conclusion

Grant Masaaki Shibuya's contributions to the field of medicinal chemistry and his innovative patents highlight his role as a key inventor in the development of new therapeutic agents. His work continues to pave the way for advancements in medical treatments.